Betta Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 39.5% in First Quarter of 2023
Listen to the full version

Betta Pharmaceuticals Co.,Ltd. (贝达药业股份有限公司) (300558.SZ) reported a net profit of 47.9 million yuan in the first quarter of 2023, down 39.5% year-on-year.
Meanwhile, the company posted 531.6 million yuan in revenue, down 9.1% year-on-year.
At the end of the reporting period, it had 8 billion yuan in total assets and 3 billion yuan in total liabilities, with a liability-to-asset ratio of 37.4%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR